The 11th World Congress for Microcirculation was held in Vancouver, Canada from September 9 to 13, 2018. Dr. Hui Xiaoli from Geriatrics Department of the First Affiliated Hospital of Xi'an Jiaotong University attended the Congress and made a poster.
World Congress for Microcirculation boasts of the largest conference of the world in the field of microcirculation. Themed “Microcirculation in Health and Disease”, this session focused on innovative research and discovery of emerging technologies, and involved research on microcirculation in health and microcirculation in diseases like diabetes, tumor, cardiovascular and cerebrovascular diseases, dementia and sepsis, as well as R&D of new drugs, attracting more than 600 researchers, scientists and clinicians in the field of microcirculation from all over the world.
Under the support from the Xi'an Jiaotong University and the hospital for attending high-level international conferences, Dr. Hui Xiaoli from Geriatrics Department attended the Congress and made a poster entitled “Neovascular Homing Peptides Dimeric GX1 Showed Antiangiogenesis to Diabetic Retinopathy and Gastric Cancer”. This paper showed that chemically modified neovascular-targeted peptide GX1 dimer with proprietary intellectual property rights in China had better inhibitory effect on diabetic retinopathy and angiogenesis in gastric cancer than the monomer. The GX1 dimer was expected to substitute the monomer and become a small peptide drug for targeted therapy of neovascularization in both diabetic retinopathy and gastric cancer. This research result is a powerful example of achievements of Geriatrics Department in the research on targeted therapy of neovascularization in diabetic retinopathy and cancer, and enhances the academic influence of the hospital on targeted therapy of neovascularization in the field of microcirculation.
